36C261-25-AP-4756-FY26-1519 Consignment DnF NCO21 Edwards Lifesciences - HCA Approved PRINT_Redacted.pdf

This document is a Determination and Findings (D&F) for a Consignment Agreement between the Department of Veterans Affairs' Palo Alto Health Care System (VAPAHCS) and Edwards Lifesciences LLC. The agreement covers the procurement of surgical implants, specifically Edwards Lifesciences EVOQUE Tricuspid Valve Replacement Systems (artificial heart valve) and PASCAL Precision Systems (implantable device for mitral valve repair). The consignment agreement will span five ordering periods from 2026 to 2030, with an indefinite delivery, indefinite quantity (IDIQ) contract structure. The primary objectives are to ensure the VAPAHCS receives necessary surgical implants as needed, reduce administrative lead times, minimize inventory investment, and prevent inventory obsolescence due to design changes. The agreement allows for flexible "just in time" purchasing without minimum purchase requirements, with products to be monitored and managed by Edwards Lifesciences LLC.